혈관성 치매
Vascular Dementia
0
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Vascular dementia (VaD) is a dementia syndrome produced by vascular damage to the brain and increases in incidence with ad- vancing age. Early Identification and diagnosis of VaD is particularly importent since its course may be modifiable through control- ling vascular risk factors. VaD is heterogeneous and consists of several syndromes : multi-infarct dementia, strategic single infarcts dementia, and subcortical vascular dementia. The diagnosis of VaD is based on several features 1) dementia, 2) evidence of cere- brovascular disease, and 3) temporal relationship between dementia and cerebrovascular disease. Treatment of VaD includes control of vascular risk factors, prevention of further vascular injury and treatment of cognitive impairment. Cholinesterase inhibitors pro- vide symptomatic benefits in treatment of VaD.
Abstract
Vascular dementia (VaD) is a dementia syndrome produced by vascular damage to the brain and increases in incidence with ad- vancing age. Early Identification and diagnosis of VaD is particularly importent since its course may be modifiable through control- ling vascular risk factors. VaD is heterogeneous and consists of several syndromes : multi-infarct dementia, strategic single infarcts dementia, and subcortical vascular dementia. The diagnosis of VaD is based on several features 1) dementia, 2) evidence of cere- brovascular disease, and 3) temporal relationship between dementia and cerebrovascular disease. Treatment of VaD includes control of vascular risk factors, prevention of further vascular injury and treatment of cognitive impairment. Cholinesterase inhibitors pro- vide symptomatic benefits in treatment of VaD.
참고문헌 (36)
- Erkinjuntti T, "Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution", Ann N Y Acad Sci, 903, pp.262~272 (2000)
- Tomlinson BE, "Observations on the brains of demented old people", J Neurol Sci, 11, pp.205~242 (1970)
- Jellinger K, "Neuropathological aspects of dementias resulting from abnormal blood and cerebrospinal fluid dynamics", Acta Neurol Belg, 76, pp.83~102 (1976)
- Ott A, "Prevalence of Alzheimer’s disease and vascular dementia: association with education", The Rotterdam study. Bmj, 310, pp.970~973 (1995)
- Skoog I, "A population- based study of dementia in 85-year-olds", N Engl J Med, 328, pp.153~158 (1993)
- Li G, "An epidemiological survey of age-related dementia in an urban area of Beijing", Acta Psychiatr Scand, 79, pp.557~563 (1989)
- Shibayama H, "Prevalence of dementia in a Japanese elderly population", Acta Psychiatr Scand, 74, pp.144~151 (1986)
- Woo JI, "Prevalence of Dementia in the Elderly Residents of a Rural Community in Korea", J Korean Neuropsychiatr Assoc, 36, pp.92~102 (1997)
- Tatemichi TK, "Dementia in stroke survivors in the Stroke Data Bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings", Stroke, 21, pp.858~866 (1990)
- Ueda K, "Prevalence and etiology of dementia in a Japanese community", Stroke, 23, pp.798~803 (1992)
- Paik Myunghee Cho, "CLINICAL DETERMINANTS OF DEMENTIA RELATED TO STROKE", ANNALS OF NEUROLOGY, 33(6), pp.568~575, LITTLE BROWN CO
- Gorelick PB, "Risk factors for dementia associated with multiple cerebral infarcts. A case-control analysis in predominantly African-American hospital- based patients", Arch Neurol, 50, pp.714~720 (1993)
- Hachinski VC, "Cerebral blood flow in dementia", Arch Neurol, 32, pp.632~637 (1975)
- Rosen WG, "Pathological verification of ischemic score in differentiation of dementias", Ann Neurol, 7, pp.486~488 (1980)
- Paik Myunghee Cho, "Meta-analysis of the Hachinski ischemic score in pathologically verified dementias", NEUROLOGY, 49(4), pp.1096~1105, LIPPINCOTT-RAVEN PUBL
- Bennett DA, "Clinical diagnosis of Binswanger’s disease", J Neurol Neurosurg Psychiatry, 53, pp.961~965 (1990)
- American Psychiatric Association, "Diagnostic and Statistical Maneual of Mental Disorders, 4th Ed (DSM-IV)" (1994), American Psychiatric Association
- Knopman DS, "Vascular dementia in a population-based autopsy study", Arch Neurol, 60, pp.569~575 (2003)
- Brust JC, "Vascular dementia is overdiagnosed", Arch Neurol, 45, pp.799~801 (1988)
- Gold G, "Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia", Neurology, 49, pp.690~694 (1997)
- Pohjasvaara T, "Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS- AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l’Enseignement en Neurosciences", Stroke, 31, pp.2952~2957 (2000)
- Roman GC, "Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop", Neurology, 43, pp.250~260 (1993)
- Mori E, "Role of functional brain imaging in the evaluation of vascular dementia", Alzheimer Dis Assoc Disord, 13(Suppl 3), pp.S91~S101 (1999)
- Scheltens P, "White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes", Eur Neurol, 39, pp.80~89 (1998)
- Roman GC, "Subcortical ischaemic vascular dementia", Lancet Neurol, 1, pp.426~436 (2002)
- Udaka F, "White matter lesions and dementia: MRI-pathological correlation", Ann N Y Acad Sci, 977, pp.411~415 (2002)
- Erkinjuntti T, "Research criteria for subcortical vascular dementia in clinical trials", J Neural Transm Suppl, 59, pp.23~30 (2000)
- Selden NR, "Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain", Brain, 121(Pt 12), pp.2249~2257 (1998)
- Swartz RH, "Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter", J Stroke Cerebrovasc Dis, 12, pp.29~36 (2003)
- Forette F, "The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study", Arch Intern Med, 162, pp.2046~2052 (2002)
- Forette F, "Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial", Lancet, 352, pp.1347~1351 (1998)
- Rockwood K, "The impact of pacemaker implantation on cognitive functioning in elderly patients", J Am Geriatr Soc, 40, pp.142~146 (1992)
- Moroney JT, "Risk factors for incident dementia after stroke. Role of hypoxic and ischemic disorders", Stroke, 27, pp.1283~1289 (1996)
- Erkinjuntti T, "Efficacy of galantamine in probable vascular dementia and Alzheimer’s disease combined with cerebrovascular disease: a randomised trial", Lancet, 359, pp.1283~1290 (2002)
- Pratt RD, "Patient populations in clinical studies of donepezil in vascular dementia", Int Psychogeriatr, 15(Suppl 1), pp.195~200 (2003)
- Orgogozo JM, "Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300)", Stroke, 33, pp.1834~1839 (2002)